AARP Eye Center
Search
Well-designed drug formularies and PDLs should be used to enhance quality and conserve resources.
An exceptions and appeals process for coverage decisions must be in place. It should be clinically sound and well-communicated.
The Federal Trade Commission should monitor relationships between pharmacy benefit managers (PBMs) and vertically integrated acquisitions for effects on consumer choice, cl
Evidence-based clinical decision support systems should be broadly integrated.
Drug companies should continue to be prohibited from promoting drugs for uses not approved by the FDA.
Reimportation and importation of prescription drugs from licensed pharmacies and wholesalers operating in Canada should be permitted with strong safety standards.